Skip to main content

Advertisement

SpringerLink
Log in

Clinico-Pathological Challenges in Managing Rare Cancers of the Vulva: Experience at a Tertiary Cancer Center in South India

  • Original Article
  • Published:
Indian Journal of Gynecologic Oncology Aims and scope Submit manuscript

Abstract

Introduction

Carcinoma of the vulva constitutes 4–5% of gynecologic malignancies with squamous cell carcinoma being the commonest. Rare histological types can cause diagnostic dilemmas and pose treatment challenges.

Aim

Clinico-pathological analysis of rare types of carcinoma vulva cases treated in our hospital and their follow-up.

Methodology

Cases diagnosed and treated at the hospital for ca vulva from January 2015 through December 2022 were included. Diagnosis, treatment details and follow-up was obtained.

Results

The rare types of cancers of the vulva during the study period included spindle cell carcinoma, neuroendocrine carcinoma, sebaceous carcinoma, metastasis from breast cancer, melanoma of vulva and adenocarcinoma of intestinal type. Spindle cell carcinoma and neuroendocrine carcinoma had poor outcomes in-spite of multi-modality treatment. Sebaceous carcinoma patient was disease free after primary radiotherapy and died due to other causes during follow-up. The patient with malignant melanoma progressed after radiotherapy, chemotherapy and immunotherapy. The patient with metastasis from breast cancer also had further disease progression leading to fatality. The young patient with adenocarcinoma of intestinal type underwent surgery and brachytherapy and is currently on follow-up.

Conclusion

Awareness of rare tumors and IHC utilization will aid in diagnosis of rare cancers of the vulva. Extrapolating management of similar tumors arising in non-gynecological areas is currently followed. Reporting rare tumors helps in further research. SCC vulva can give good survival whereas the rare tumors may present with early recurrences and progression despite multi-modality approach.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Virarkar M, Vulasala SS, Daoud T, Javadi S, Lall C, Bhosale P. Vulvar cancer: 2021 revised FIGO staging system and the role of imaging. Cancers [Internet]. 2022 May [cited 2023 Oct 6];14(9). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9102312/

  2. Steeper TA, Piscioli F, Rosai J. Squamous cell carcinoma with sarcoma-like stroma of the female genital tract. Clinicopathologic study of four cases. Cancer. 1983;52(5):890–8.

    Article  CAS  PubMed  Google Scholar 

  3. Choi DS, Lee JW, Lee SJ, Choi CH, Kim TJ, Lee JH, et al. Squamous cell carcinoma with sarcomatoid features of the vulva: a case report and review of literature. Gynecol Oncol. 2006;103(1):363–7.

    Article  PubMed  Google Scholar 

  4. Petrillo M, Corrado G, Carbone A, Macchia G, Ferrandina G. Vulvar squamous cell carcinoma with sarcoma-like stroma: a case report and review of the literature. Diagn Pathol. 2011;1(6):95.

    Article  Google Scholar 

  5. Trietsch MD, Peters AAW, Gaarenstroom KN, van Koningsbrugge SHL, ter Haar NT, Osse EM, et al. Spindle cell morphology is related to poor prognosis in vulvar squamous cell carcinoma. Br J Cancer. 2013;109(8):2259–65.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Correia A, Branco EC, Correia P, Guimarães M, Sá L. Small cell carcinoma of the vulva: case report. Clin Pract. 2017;7(2):918.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Gardner GJ, Reidy-Lagunes D, Gehrig PA. Neuroendocrine tumors of the gynecologic tract: a Society of Gynecologic Oncology (SGO) clinical document. Gynecol Oncol. 2011;122(1):190–8.

    Article  PubMed  Google Scholar 

  8. Chen PP, Ramalingam P, Alvarado-Cabrero I, Euscher ED, Nagarajan P, Lawson BC, et al. High-grade neuroendocrine carcinomas of the vulva: a clinicopathologic study of 16 cases. Am J Surg Pathol [Internet]. 2021 Mar 1 [cited 2023 Oct 7];45(3). Available from: https://pubmed.ncbi.nlm.nih.gov/32826525/

  9. Chang TC, Lai CH, Tseng CJ, Hsueh S, Huang KG, Chou HH. Prognostic factors in surgically treated small cell cervical carcinoma followed by adjuvant chemotherapy. Cancer. 1998;83(4):712–8.

    Article  CAS  PubMed  Google Scholar 

  10. Embry JR, Kelly MG, Post MD, Spillman MA. Large cell neuroendocrine carcinoma of the cervix: prognostic factors and survival advantage with platinum chemotherapy. Gynecol Oncol. 2011;120(3):444–8.

    Article  PubMed  Google Scholar 

  11. George J, Walter V, Peifer M, Alexandrov LB, Seidel D, Leenders F, et al. Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors. Nat Commun. 2018;9(1):1048.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Muir-Torre syndrome - PubMed [Internet]. [cited 2023 Oct 7]. Available from: https://pubmed.ncbi.nlm.nih.gov/16321766/

  13. Dasgupta T, Wilson LD, Yu JB. A retrospective review of 1349 cases of sebaceous carcinoma. Cancer. 2009;115(1):158–65.

    Article  PubMed  Google Scholar 

  14. Na HY, Choe JY, Shin SA, Choung HK, Oh S, Chung JH, et al. Proposal of a provisional classification of sebaceous carcinoma based on hormone receptor expression and HER2 status. Am J Surg Pathol. 2016;40(12):1622–30.

    Article  PubMed  Google Scholar 

  15. Radiation therapy for local control of eyelid sebaceous cell carcinoma: report of two cases and review of the literature - PubMed [Internet]. [cited 2023 Oct 7]. Available from: https://pubmed.ncbi.nlm.nih.gov/10826762/

  16. Sebaceous carcinoma responds to radiation therapy - PubMed [Internet]. [cited 2023 Oct 7]. Available from: https://pubmed.ncbi.nlm.nih.gov/8570154/

  17. Alharthi H, Alnuaim H, Aljarbou O, Arabi H. Sebaceous carcinoma of the vulva: a case report and review of the literature. Avicenna J Med. 2021;11(1):49–53.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Neto AG, Deavers MT, Silva EG, Malpica A. Metastatic tumors of the vulva: a clinicopathologic study of 66 cases. Am J Surg Pathol. 2003;27(6):799–804.

    Article  PubMed  Google Scholar 

  19. Alligood-Percoco NR, Kessler MS, Willis G. Breast cancer metastasis to the vulva 20 years remote from initial diagnosis: a case report and literature review. Gynecol Oncol Rep. 2015;27(13):33–5.

    Article  Google Scholar 

  20. Perrone G, Altomare V, Zagami M, Vulcano E, Muzii L, Battista C, et al. Breast-like vulvar lesion with concurrent breast cancer: a case report and critical literature review. In Vivo. 2009;23(4):629–34.

    PubMed  Google Scholar 

  21. Wohlmuth C, Wohlmuth-Wieser I, May T, Vicus D, Gien LT, Laframboise S. Malignant melanoma of the vulva and vagina: a US population-based study of 1863 patients. Am J Clin Dermatol. 2020;21(2):285–95.

    Article  PubMed  Google Scholar 

  22. Dobrică EC, Vâjâitu C, Condrat CE, Crețoiu D, Popa I, Gaspar BS, et al. Vulvar and vaginal melanomas-the darker shades of gynecological cancers. Biomedicines. 2021;9(7):758.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Rouzbahman M, Kamel-Reid S, Habeeb AA, Butler M, Dodge J, Laframboise S, et al. Malignant melanoma of vulva and vagina: a histomorphological review and mutation analysis--a single-center study. J Low Genit Tract Dis [Internet]. 2015 Oct [cited 2023 Oct 9];19(4). Available from: https://pubmed.ncbi.nlm.nih.gov/26225944/

  24. Lian B, Si L, Cui C, Chi Z, Sheng X, Mao L, et al. Phase II randomized trial comparing high-dose IFN-α2b with temozolomide plus cisplatin as systemic adjuvant therapy for resected mucosal melanoma. Clin Cancer Res Off J Am Assoc Cancer Res. 2013;19(16):4488–98.

    Article  CAS  Google Scholar 

  25. D’Angelo SP, Larkin J, Sosman JA, Lebbé C, Brady B, Neyns B, et al. Efficacy and safety of nivolumab alone or in combination with ipilimumab in patients with mucosal melanoma: a pooled analysis. J Clin Oncol Off J Am Soc Clin Oncol. 2017;35(2):226–35.

    Article  Google Scholar 

  26. Schiavone MB, Broach V, Shoushtari AN, Carvajal RD, Alektiar K, Kollmeier MA, et al. Combined immunotherapy and radiation for treatment of mucosal melanomas of the lower genital tract. Gynecol Oncol Rep. 2016;16:42–6.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Twyman-Saint Victor C, Rech AJ, Maity A, Rengan R, Pauken KE, Stelekati E, et al. Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer. Nature. 2015;520(7547):373–7.

    Article  CAS  PubMed  Google Scholar 

  28. Tiltman AJ, Knutzen VK. Primary adenocarcinoma of the vulva originating in misplaced cloacal tissue. Obstet Gynecol. 1978;51(1 Suppl):30s-s33.

    CAS  PubMed  Google Scholar 

  29. Dellino M, Cicogna S, Falcone F, Mitidieri M, Mazzeo R, Pignata S, et al. “Intestinal-type” vulvar adenocarcinoma: a review of the MITO rare tumors group. Cancers. 2022;14(20):5171.

    Article  CAS  PubMed  Google Scholar 

  30. Sopracordevole F, Azzalini G, Clemente N, Fabro AD, Giorda G, Fichera M, et al. Primary intestinal-type adenocarcinoma of the vulva. A case report and review of the literature. Gynecol Oncol Rep [Internet]. 2023 Jun [cited 2023 Oct 18];47. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10149392/

  31. Musella A, Marchetti C, Salerno L, Vertechy L, Iadarola R, Pecorella I, et al. An unexpected complete remission of advanced intestinal-type vulvar adenocarcinoma after neoadjuvant chemotherapy: a case report and a literature review. Case Rep Obstet Gynecol. 2013;2013: 427141.

    PubMed  PubMed Central  Google Scholar 

  32. Kaltenecker B, Manos R, McCall M, Sparzak P. Intestinal-type adenocarcinoma of the vulva: A case study. Gynecol Oncol Rep [Internet]. 2019 Mar 29 [cited 2023 Oct 18];28. Available from: https://pubmed.ncbi.nlm.nih.gov/31061870/

  33. Gershenwald JE, Scolyer RA, Hess KR, et al. Melanoma of the Skin Amin M, Edge SB, Greene FL, et al. eds. AJCC Cancer Staging Manual. 8th ed. Switzerland: Springer; 2017:563–585.

Download references

Author information

Authors and Affiliations

  1. Department of Gynecologic Oncology, Sri Shankara Cancer Hospital and Research Center, Shankarpuram, Bengaluru, India

    Rekha Raghavendrachar & Vadaparty Annapurna

  2. Department of Pathology, Sri Shankara Cancer Hospital and Research Center, Bengaluru, India

    K. P. Divyamala

  3. Department of Radiation Oncology, Sri Shankara Cancer Hospital and Research Center, Bengaluru, India

    Karthik S. Rishi

  4. Department of Gynecologic Oncology, B.L.Kapoor-Max Super Speciality Hospital, New Delhi, India

    Munisha Sharma

Authors
  1. Rekha Raghavendrachar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Vadaparty Annapurna
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K. P. Divyamala
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Karthik S. Rishi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Munisha Sharma
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Vadaparty Annapurna.

Ethics declarations

Funding and/or Conflicts of Interests/Competing Interests

The authors have no relevant financial or non-financial interests to disclose.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 14340 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Raghavendrachar, R., Annapurna, V., Divyamala, K.P. et al. Clinico-Pathological Challenges in Managing Rare Cancers of the Vulva: Experience at a Tertiary Cancer Center in South India. Indian J Gynecol Oncolog 22, 84 (2024). https://doi.org/10.1007/s40944-024-00834-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s40944-024-00834-9

Keywords

Search

Navigation